Overexpression and transmembrane delivery of OCT4 in MM has been demonstrated to drive dedifferentiation to CSC-like cells, with associated resistance to chemotherapy and hypoxia, and increased tumorigenesis [58]. The gene discussed is POU5F1; the disease is Miyoshi myopathy.